It seems no one is taking covid-19 seriously anymore, said Mollee Loveland, a nursing home aide who lives outside Pittsburgh. Loveland has seen patients and coworkers at the nursing home where she works die from the viral disease. Now she has a new worry: bringing home the coronavirus and unwittingly infecting her infant daughter, Maya,…
With Donald Trump’s return to the White House and Republicans taking full control of Congress in 2025, the Affordable Care Act’s Medicaid expansion is back on the chopping block. More than 3 million adults in nine states would be at immediate risk of losing their health coverage should the GOP reduce the extra federal Medicaid…
Lyle Berkowitz is an old friend and these days is CEO of Keycare, which provides a virtual care workforce, primarily for major health systems. It’s based on Epic taking advantage of Telehealth Everywhere, which means that patients can get to them from within their MyChart accounts and it can easily integrate its EMR data with…
That is the title of an interview with me in The Evidence Base out today with the subtitle Introducing generalized cost effectiveness analysis for a comprehensive value assessment. Below is an excerpt: What is this paper about? What is new in this paper?Our recent publication presents a comprehensive framework for evaluating the societal value of health technologies,…
GE HealthCare made a slew of announcements at RSNA 2024, including an acquisition, new machines for mammography and SPECT/CT imaging, and new AI features to help improve radiologist workflows. The post 4 Announcements GE HealthCare Made at RSNA 2024 appeared first on MedCity News.
Merative, a data, analytics and technology provider, is Morgan Health’s eighth portfolio company. The investment will help accelerate growth. The post Morgan Health Commits $25M to Merative to Enhance Employer Data Capabilities appeared first on MedCity News.
This updated fact sheet examines the U.S. role in the Global Fund, an independent, multilateral financing entity that raises significant new resources to combat HIV/AIDS, tuberculosis (TB), and malaria in low- and middle- income countries.
Keros Therapeutics will present Phase 2 data for the drug, elritercept, at the annual meeting of the American Society of Hematology. Meanwhile, the Takeda deal enables Keros to focus on two wholly owned assets, one of which could compete with a Merck drug approved earlier this year. The post Takeda Pays $200M for Keros Therapeutics…
A new issue brief based on focus groups conducted by KFF among NHPI adults living in Hawaii and the continental U.S. highlights barriers NHPI people face when accessing health care, including geographic isolation, limited system capacity, and language access. In their own words, participants describe both positive and negative experiences in health care settings and…
Among NHPI people, there is significant variation in key factors that influence health, including health coverage, income, and homeownership, with Marshallese people faring the worst across all examined measures. Data gaps prevent the ability to fully identify and understand health disparities for NHPI people. Among available data, NHPI people fare worse than White people for…